Covalent Drug Discovery by Chemoproteomics: Deconvolution of Phenotypic Screening Hits Through IMTAC Proteome-Wide, Live-Cell Screening
Time: 11:30 am
day: Conference Day 1
Details:
- Discussing the advantages of IMTAC proteome-wide, live-cell screening to further drug discovery efforts
- Identification of novel targets with the potential to overcome acquired chemotherapy resistance in high-grade serous ovarian cancer
